INDUSTRY SPONSORED SATELLITE SYMPOSIA

INDUSTRY SPONSORED SATELLITE SYMPOSIA
Industry Sponsored Satellite Symposia are sessions that are planned and conducted by the corporate community in
conjuntion with ECO2015. They provide attendees with additional educational/informational opportunities but are
not part of the official ECO2015 scientific programme.
Wednesday, 6 May 2015
1600 – 1730: PANORAMA HALL
“Evidence-based weight loss and maintenance with formula diet”
Aim: To examine the evidence for the effectiveness of formula diet weight loss and maintenance programmes.
Objectives:
• To review the evidence for weight loss and maintenance associated with meaningful medical end-points, and
identify further research needs.
• To review the evidence for weight loss before bariatric and knee replacement surgery, determine whether weight
loss is needed, review evidence for costs and benefits of weight loss.
• To review the evidence for the use of formula diet to achieve weight loss in diabetes, describe ongoing trials and
describe likely costs and benefits.
• To examine the evidence for weight loss and maintenance in obesity-associated inflammatory disease focussing
on osteoarthritis, review evidence for costs and benefits of weight loss and maintenance.
Chair: Anthony R Leeds, University of Copenhagen, Denmark and University of Surrey, UK
Slim for surgery: why and how
Omar Khan (bariatric surgery) Whittington Hospital, London, UK; and Henning Bliddal (orthopaedic surgery), Parker
Institute, Frederiksberg Hospital, Copenhagen, Denmark
Diabetes reversal with formula diet
Naomi Brosnahan, DiRECT study, University of Glasgow, UK
Suppressing inflammatory disease: weight loss and maintenance in osteoarthritis and psoriasis Henning Bliddal,
Parker Institute, Frederiksberg Hospital, University of Copenhagen, Denmark
Discussion led by Anthony R Leeds
Wednesday, 6 May 2015
1600 – 1730: FORUM HALL
“New perspectives in weight management”
Welcome and introduction
Nick Finer (chair) (UK)
Novel targets for weight loss
Lotte Bjerre Knudsen (Denmark)
Emerging approaches to weight management
Nick Finer (UK)
In people with and without prediabetes
David Lau (Canada)
In people with type 2 diabetes
Luc van Gaal (Belgium)
Panel discussion
All faculty
Thursday, 7 May 2015
1315 – 1445: MEETING HALL 1
“Scalable Solutions to Manage Obesity and Type 2 Diabetes”
Obesity and type 2 diabetes are diseases that can substantially decrease life expectancy, diminish quality of life and
increase healthcare costs. There is a close connection between obesity and diabetes, with almost 85% of people with
diabetes being overweight or obese. While behavioral lifestyle modification programs have well-documented effects
on preventing diabetes, and improving glycemic control among those with diabetes, most programs are offered in a
specialized research setting with limited reach. This interactive symposium of leading weight management and
diabetes experts, from Europe and the United States, will present new research on effective, scalable communitybased treatment options for both the prevention and treatment of obesity and diabetes.
Obesity, Diabetes and Weight Loss
Luc Van Gaal, PhD, Professor of Medicine, Department of endocrinology, diabetology and metabolic diseases, Antwerp
University Hospital (UZA), Antwerp University, Netherlands
Effects on Glycemic Control and Weight of the Weight Watchers Program Tailored for People with Type 2 Diabetes
Patrick M. O'Neil, PhD, Weight Management Center, Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina, USA
Moving the Prevention of Type 2 Diabetes into the Broader Public Health: The Promise of a Commercial Weight Loss
Program to Scale Prevention Efforts
David G Marrero, PhD, J.O. Ritchey Professor of Medicine, Director, Diabetes Translational Research Center
Indiana University School of Medicine, USA
Thursday, 7 May 2015
1745 – 1945: PANORAMA HALL
“Sweeteners and Health: Findings from Recent Research and their Impact on Obesity and Related Metabolic
Conditions.”
The Metabolism of Fructose Containing Sugars and Clinical Implications.
Luc Tappy, M.D., Département de Physiologie, Lausanne, Switzerland
How convincing is the sugar addiction model?
Professor David Benton, Department of Psychology, University of Swansea, Wales, United Kingdom
Effects of Sugar on Obesity and Related Conditions: Findings from Recent Systematic Reviews and Meta-analyses
John L Sievenpiper, MD, PhD, Knowledge Synthesis Lead, Toronto 3D Knowledge Synthesis and Clinical Trials Unit,
Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Canada
Sugars and Cardiovascular Disease
James Rippe, M.D. Rippe Lifestyle Institute, Shrewsbury, MA, USA
Friday, 8 May 2015
1315 – 1445: PANORAMA HALL
MIND AND BODY IN LONG-TERM WEIGHT LOSS
Programme Chair
Hermann Toplak, Austria
13:15–13:20
Welcome and introduction
Hermann Toplak, Austria
13:20–13:35
Physiological mechanisms of weight control and responses to weight loss
Uberto Pagotto, Italy
13:35–13:50
Targeting the brain–gut axis for weight control
Jason Halford, UK
13:50–14:05
Strategies for maintaining long-term weight control
Hermann Toplak, Austria
14:05–14:40
Putting it in to practice
All faculty
This symposium is supported by an educational grant from Novo Nordisk A/S.
®
An application has been made to the EACCME for CME accreditation of this event.
Friday, 8 May 2015
1315 – 1445: MEETING HALL 1
Title and Content TBC